XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

Markets GlobeNewswire By GlobeNewswire 10 Sep 2026 20:05 1 min read
XORTX Announces Initiation of Clinical and Commercial Manufacturing of XORLO™

● Contract manufacturing of GMP drug substance and commercial-scale tablets to support the XRX-OXY-102 clinical study and future US FDA marketing approval ●

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Call it yourself

No calls on $XRX yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Xerox Holdings Corp →
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.